- Lobbying
- connect AND 4 AND strategies
Lobbying Arrangements Results for 'Connect 4 Strategies'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details General pharmaceutical issues awareness |
Akcea Therapeutics, Inc.
|
Connect 4 Strategies, LLC | |||
Details Priority Review Voucher implementation |
Imara, Inc.
|
Connect 4 Strategies, LLC | |||
Details Medical Device User Fee Act of 2017 |
Binge Eating Disorder Association
|
Connect 4 Strategies, LLC | |||
Details Medicare part B and D |
Alpha-1 Foundation
|
Connect 4 Strategies, LLC | |||
Details Medical Device User Fee Act of 2017 |
National Eating Disorder Assocciation
|
Connect 4 Strategies, LLC | |||
Details CMS Coding process |
Ferring Pharmaceuticals, Inc.
|
Connect 4 Strategies, LLC | |||
Details Undertake advocacy efforts for US AgainstAlzheimer's. |
Connect 4 Strategies on behalf of USAgainstAlzheimer's
|
NormInc | |||
Details Rare pediatric review voucher. S 1878 and HR 1537 |
Biomarin Pharmaceutical Inc.
|
Connect 4 Strategies, LLC | |||
Details Warren Grassley Bill - OTC Hearing Aid Legislation |
Starkey Hearing Technologies
|
Connect 4 Strategies, LLC | |||
Details CMS Issues |
Recordati Rare Diseases
|
Connect 4 Strategies, LLC | |||
Details Ultra-rare disease health care issues |
The Haystack Project
|
Connect 4 Strategies, LLC | |||
Details Pediatric Priority review vouchers. HR1573 and S1878. HR1573 & S1878 Pediatric Pediatric Priority Review Voucher |
Therabron Therapeutics, Inc
|
Connect 4 Strategies, LLC | |||
Details The Change Act |
UsAginastAlzheimer's Network
|
Connect 4 Strategies, LLC | |||
Details HEART Act HR 1184 and S 4071 |
FCS Foundation
|
Connect 4 Strategies, LLC | |||
Details General Issue Awareness and Education |
USAgainstAlheimer's
|
Connect 4 Strategies, LLC | |||
Details Issues related to porphyria patients access to treatment. |
Connect 4 Strategies, LLC (on behalf of Recordati Rare Diseases)
|
Sims Strategies, LLC | |||
Details HR 1537 Rare pediatric priority review voucher |
Mast Therapeutics, Inc.
|
Connect 4 Strategies, LLC | |||
Details Legislative and regulatory issues related to Orexo |
Orexo US, inc.
|
Connect 4 Strategies, LLC | |||
Details Pediatric vouchers. H.R. 6, 21st Century Cures Act. |
Connect 4 Strategies, LLC (on behalf of Agilis Biotherapeutics)
|
Mehlman Castagnetti Rosen & Thomas, Inc. | |||
Details Monitored telecommunications legislation and regulation generally, with specific lobbying emphasis upon the following issues: 1) consideration of any update or rewrite of current telecommunication... |
Frontier Communications
|
MERCURY STRATEGIES, LLC | |||
Details Medication assisted treatment for Opioid use disorder, implementation. H.R. 5202/S. 916 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018. H.R. 6 - SUPPORT for Patients and... |
Connect 4 Strategies, LLC (on behalf of Orexo)
|
Mehlman Castagnetti Rosen & Thomas, Inc. | |||
Details Increased access to Panhematin |
Connect 4 Strategies, LLC (on behalf of Recordati Rare Diseases)
Healthcare Consultancy |
Mehlman Castagnetti Rosen & Thomas, Inc. | |||
Details FDA and Pediatric Rare Disease Voucher Review Program. Cures and Innovation; Sickle Cell. FDA and Pediatric Rare Disease Voucher Program. |
Connect 4 Strategies, LLC (on behalf of Mast Therapeutics, Inc.)
Healthcare consulting |
Mehlman Castagnetti Rosen & Thomas, Inc. |